Nepafix 0.1% (Ophthalmic Suspension)

5 ml drop: ৳ 150.00

Medicine Details

Category Details
Generic Nepafenac
Company Healthcare pharmaceuticals ltd
Also available as
Nepafix ts 03 suspension

Indications

  • The treatment of post-operative ocular pain and inflammation including cataract surgery
  • Inhibition of surgery induced miosis
  • Prevention of post-operative cystoid macular edema (CME)
  • Post-operative pain and inflammation associated with cataract surgery

Pharmacology

  • Nepafenac is a nonsteroidal anti-inflammatory prodrug (NSAID)
  • Penetrates the cornea and is converted by ocular tissue hydrolase to Amfenac, a potent nonsteroidal anti-inflammatory drug
  • Thought to inhibit the action of cyclooxygenase enzyme required for prostaglandin synthesis

Dosage & Administration

  • Instill 1 drop 3 times daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period
  • Instill 1 drop 3 times daily 1 day before surgery & on the day of surgery for surgery induced miosis
  • Instill 1 drop once daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period for 0.3% suspension
  • An additional drop should be administered 30 to 120 minutes prior to surgery for 0.3% suspension

Contraindications

  • Contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation or to other NSAIDs

Side Effects

  • Foreign body sensation
  • Lid margin crusting
  • Ocular discomfort
  • Ocular hyperemia

Pregnancy & Lactation

  • Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Nepafenac should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
  • Use in lactation: It is not known whether this drug is excreted in human milk. So, caution should be exercised when Nepafenac ophthalmic suspension is administered to a nursing mother

Precautions & Warnings

  • Should be used with caution in patients with known bleeding tendencies or who are receiving medications which may prolong bleeding time

Use in Special Populations

  • Use in children: Safety and effectiveness in pediatric patients below 18 years of age have not been established
  • No overall differences in safety or effectiveness have been observed between elderly and younger patients

Therapeutic Class

  • Ophthalmic Non-Steroid drugs

Related Brands